dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Garrigós Cubells, Laia |
dc.contributor.author | Martinez-Vila, Clara |
dc.contributor.author | Zambelli, Alberto |
dc.contributor.author | Bower, Mark |
dc.contributor.author | Pistilli, Barbara |
dc.contributor.author | Aguilar Company, Juan |
dc.contributor.author | Ruiz Camps, Isabel |
dc.contributor.author | Saura Manich, Cristina |
dc.contributor.author | Pla, Helena |
dc.date.accessioned | 2022-05-20T10:16:10Z |
dc.date.available | 2022-05-20T10:16:10Z |
dc.date.issued | 2021-11-02 |
dc.identifier.citation | Garrigós L, Saura C, Martinez-Vila C, Zambelli A, Bower M, Pistilli B, et al. COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry. Ther Adv Med Oncol. 2021 Nov 2;13:1–11. |
dc.identifier.issn | 1758-8359 |
dc.identifier.uri | https://hdl.handle.net/11351/7560 |
dc.description | COVID-19; SARS-CoV-2; Càncer de mama |
dc.description.sponsorship | D.J. Pinato is supported by grant funding from the Wellcome Trust Strategic Fund (PS3416) and acknowledges grant support from the Cancer Treatment and Research Trust (CTRT), infrastructural and grant support by the Cancer Research UK Imperial Centre and the NIHR Imperial Biomedical Research Centre. A. Gennari is supported by the AIRC IG Grant, No. 14230, Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy and acknowledge also support from the UPO Aging Project. |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Therapeutic Advances in Medical Oncology;13 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | COVID-19 (Malaltia) - Mortalitat |
dc.subject | COVID-19 (Malaltia) - Complicacions |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | /complications |
dc.subject.mesh | Mortality |
dc.title | COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/17588359211053416 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | /complicaciones |
dc.subject.decs | mortalidad |
dc.relation.publishversion | https://doi.org/10.1177/17588359211053416 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Garrigós L] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Saura C] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Head Breast Cancer Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martinez-Vila C] Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain. [Zambelli A] Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. [Bower M] Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK. [Pistilli B] Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France. [Aguilar Company J] Servei d’Oncologia Mèdica i Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pla H] Departament d'Oncologia Institut Català d'Oncologia, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain |
dc.identifier.pmid | 34777582 |
dc.identifier.wos | 000714016500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |